Reshaping the Mosquito Control Industry

SOL_VDCI_Day1_finals_2915_737

Every year, new technologies emerge that help keep people safer, healthier, and happier. This includes technologies used in the mosquito management industry.

Vector-borne diseases spread by mosquitoes are responsible for killing more than one million people annually. That’s why the development of new innovations is key in the mission to prevent mosquitoes from endangering communities worldwide. 

When we choose to utilize advanced technologies, it’s because they enhance the accuracy, efficacy, and safety of our work. Here are some of the innovations we utilize as part of mosquito surveillance programs and Integrated Mosquito Management programs to help keep the communities we serve safe.

Without data, it’s difficult to understand the effectiveness of mosquito control efforts or fully demonstrate to stakeholders the financial return of their investment. It’s also more challenging to strategize an effective management plan. GIS mapping can be utilized in nearly every facet of an integrated mosquito management program, from tracking larval and adulticide applications to monitoring mosquito populations and disease data via mosquito surveillance equipment. Over time, this information can be analyzed to identify trends or patterns and determine the overall impact of treatment efforts.

arcmap_biggerBeyond the day to day operations of an IMM program, GIS technology has several other applications. GIS serves as a critical tool for regulatory compliance, as maps can be used to both assure compliance and also streamline requirements for initiatives like NPDES permitting. Through mosquito surveillance, maps that show disease monitoring in a given area can also be used to support public education and communications throughout the community. Lastly, federal, state, and local governments use GIS to aid in emergency response efforts.

Mosquito Surveillance Traps and Lab Analysis

Mosquito Surveillance & Disease Testing Reduce Mosquito-borne Disease 3Mosquito surveillance traps are not used to control adult mosquitoes; rather, they serve as an important mosquito surveillance tool for collecting data on species distribution, population dynamics, and calculating disease risk based on vector competence.

Our professionals utilize several types of mosquito surveillance traps, including the CDC Miniature Light Trap, Gravid Trap, BG-Sentinel, and New Jersey Light Trap, just to name a few.  Collection, counting, and identification of the mosquitoes through a mosquito surveillance program help staff determine which abatement solutions should be employed.  Once collected, mosquitoes also undergo professional testing and analysis at the lab. Oftentimes, the diseases mosquitoes can transmit can be detected in the mosquitoes themselves weeks before they can be passed on to their human and animal hosts. This gives mosquito management experts a window of opportunity to take action to reduce the risk of human disease transmission in the local community and is one of the reasons that mosquito surveillance programs are so vital.

Mosquito management professionals utilize several technologies when conducting larviciding and adulticiding applications. Data gathered from mosquito surveillance programs ensures that we are spraying in the right places and at the right time.

CDCMosquito-adult-larviciding-2-scaled

Ground Application Technology

For smaller areas, crews may choose to perform ground applications using either backpacks or power sprayers capable of holding 2-100 gallons of product.  Whether an application is done by hand or with specialized truck-based equipment, they’re calibrated frequently, and all applications are recorded in VDCI”s proprietary database.  

Planes

For large areas that need to be treated quickly or places you simply can’t access with vehicles, aerial fleets are the go-to option. VDCI operates one of the world’s largest aerial fleets dedicated to mosquito control and services customers from coast to coast.

Aerial Spraying Malcom 9

Aircraft equipped for adult mosquito control utilize the Wingman® GX spray optimization and guidance software in addition to an AIMMS-20 onboard meteorological probe to ensure the most effective application possible. This integrated system is the only scientifically validated one of its kind that incorporates constant real-time meteorological data at the release height to optimize the entire application. This optimization ensures that the maximum spray cloud droplet density is delivered to the target zones, thus providing you with the maximum level of mosquito control.

Each member of VDCI’s flight crew is highly trained and licensed through the Federal Aviation Administration (FAA). Crews utilize military-grade ANVIS -6 night vision goggles on all nighttime spray missions to increase visibility and accuracy. At the completion of each spray mission, data is downloaded from the aircraft, and reports are generated, providing our customers with a visual depiction of the spray mission, along with the vital statistics of each spray.

Unmanned Aerial Drones

Recent advancements in drone technology have provided a new way to reach and treat areas that were previously inaccessible via ground or plane.

drones mosquito management

Our drones are custom-built by Leading Edge Aerial Technologies, Inc. for commercial applications. Each drone exhibits a 6ft wingspan and is equipped with superior features that are operated remotely by a professional team. Drones are supported by GPS technology to access mapped target sites and guide precision applications using granular products. They are also configured with state-of-the-art software that blocks filming, so homeowners can have peace of mind while drone applications occur nearby.

VDCI Remains At The Forefront of Vector Industry Advancements

VDCI is committed to staying at the forefront of technological advancements in mosquito surveillance and mosquito control, and creating new standards for safety and efficiency. We employ a wide array of technology, ranging from mosquito surveillance tools to advanced software systems to state-of-the-art application equipment, to provide you with the most comprehensive mosquito surveillance and management services possible. Contact or call our experts at 800-413-4445 to discuss the most effective control solutions for your community.

VDCI Wants To Make Your Property Safer.
How Can We Help?

Fill out the information below, and one of our experts will follow up with you shortly.

VDCI_Logo_squareSince 1992, Vector Disease Control International (VDCI) has taken pride in providing municipalities, mosquito abatement districts, industrial sites, planned communities, homeowners associations, and golf courses with the tools they need to run effective mosquito control programs. We are determined to protect the public health of the communities in which we operate. Our mosquito control professionals have over 100 years of combined experience in the field of public health, specifically vector disease control. We strive to provide the most effective and scientifically sound mosquito surveillance and control programs possible based on an Integrated Mosquito Management approach recommended by the American Mosquito Control Association (AMCA) and Centers for Disease Control and Prevention (CDC). VDCI is the only company in the country that can manage all aspects of an integrated mosquito management program, from surveillance to disease testing to aerial application in emergency situations.

Educating Your Community Can Help Eliminate Mosquito-Borne Diseases

PublicEducation VDCI mosquito control - teachers portal - research and resources

Personal Protection & Property Maintenance Tips

mosquito bite on arm msquito control public educationWe’re all impacted by the presence of mosquitoes – in more ways than you might know. Itchy bites are often a harmless annoyance, but the spread of mosquito-borne disease can have disastrous consequences for both humans and animals. Proactive integrated mosquito management (IMM) is the most effective way to limit their populations. VDCI partners with city, county, and state governments as well as mosquito abatement districts and public health entities to protect residents and visitors to their community. Depending on the species of mosquito in your area, public education can play a critical role in preventing mosquito development and bites can be minimized with the use of EPA approved repellents and personal protective clothing. 

Mosquitoes Are a Threat to Public Health

You may have heard about common diseases like West Nile virus, malaria, Eastern Equine Encephalitis, Yellow Fever, Zika, dengue and others. It can be easy to brush off the transmission of these pathogens as extremely rare instances, but the reality is mosquitoes spread more disease than any other species on earth, resulting in approximately one million deaths annually. Victims of these diseases can experience severe complications, including flu-like symptoms, allergic reactions, brain and nervous system inflammation, permanent physical and mental disabilities, or birth defects. Mosquitoes are also responsible for transmitting deadly parasitic heartworms to cats, dogs, and other wildlife.

We Each Play a Role

Mosquitoes have existed on earth for millions of years and with over 3,000 unique species  they won’t be eradicated any time soon. There are numerous ways to reduce mosquito populations in your area and they all begin with an understanding of species biology and empowering community members to take personal protective measures.

Eliminating Mosquito Habitat

Public Education in Reducing Mosquito Populations 1Mosquitoes require standing water to develop. A single female can lay anywhere from 200-300 eggs and utilize habitats as small as a bottle cap.  When it’s hot outside these larvae can develop into biting adult mosquitoes in less than 4 days!  Some of the sites we frequently find in backyards include clogged gutters, old tires, and potholes or depressions near sprinkler heads. You can do your part to help eliminate mosquitoes by emptying outdoor containers such as cups, buckets, flower pots, bird baths, and watering cans. Likewise, take steps to ensure water properly drains off of tarps, tables, and outdoor equipment during rainstorms.

Personal Protection Against Mosquito Bites (Repellent and Clothing)

While reducing mosquito habitat on your property can make a significant difference in the battle against mosquitoes, many species are capable of flying several miles to take a blood meal.  Because of this it’s also important for you to wear protective clothing and use an EPA approved repellent when biting pressure is high or transmittable diseases have been identified in local populations. Wear light-colored clothing, closed toe shoes, long-sleeves, and long pants when spending time outside can reduce your likelihood of being bitten. This is especially important around dawn or dusk when mosquitoes tend to be most active. Bare skin on hands, ankles or face should be protected with repellent or covered when possible. For the safe and effective use of any product, always read the label and follow manufacturer guidelines.

Public Education Is Imperative

Public participation can play an important role in reducing local mosquito populations and preventing transmission of disease. The tools used to control mosquitoes are diverse and often misunderstood. Partnering with a professional mosquito management organization can help ensure community members receive the most accurate and effective information about the mosquito species, diseases, and tools used in your area. This is a core pillar in any successful mosquito control program that municipalities, health departments, churches, schools, and other community groups must prioritize when getting started. 

person-showing-protection-plan

The science behind mosquito management is foundational to everything we do and application strategies continue to develop as environmental conditions shift and management solutions become more advanced. Whether a project requires targeted ground operations or large-scale efforts using drones and aerial fleets, VDCI helps stakeholders design the most productive and economical approach.

Contact Us to Build A Public Education Program for Your Community

VDCI_Logo_squareSince 1992, Vector Disease Control International (VDCI) has taken pride in providing municipalities, mosquito abatement districts, industrial sites, planned communities, homeowners associations, and golf courses with the tools they need to run effective mosquito control programs. We are determined to protect the public health of the communities in which we operate. Our mosquito control professionals have over 100 years of combined experience in the field of public health, specifically vector disease control. We strive to provide the most effective and scientifically sound mosquito surveillance and control programs possible based on an Integrated Mosquito Management approach recommended by the American Mosquito Control Association (AMCA) and Centers for Disease Control and Prevention (CDC). VDCI is the only company in the country that can manage all aspects of an integrated mosquito management program, from surveillance to disease testing to aerial application in emergency situations.

2018 Mosquito-Borne Disease Year in Review

person-in-lab-looking-at-mosquitoes

Explore the Mosquito-Borne Diseases Reported In Your Region

Official reports on vector-borne diseases, severe weather, and changes in our climate were repeated in various media outlets last year. The attention brought heightened awareness to a number of disease-carrying pests, with a lot of the attention on – the mosquito. For this article, we will provide a brief overview of mosquito-borne disease reporting to the Centers for Disease Control and Prevention (CDC) in 2018. We will also discuss lesser known mosquito-borne diseases, and the CDC report that highlighted an increase in vector-borne disease reporting over the last decade.

Vector-borne disease transmission cycles are complex. They involve a variety of interconnected environmental parameters – meaning that predicting where they will be prevalent in any given year is difficult. However, we will also briefly cover what is currently being reported in 2019.

Mosquito-Borne Disease Activity Right Now

Before we revisit 2018, you may be curious about the mosquito-borne disease activity at present. As of July 23, 2019, a total of 34 states have reported West Nile virus (WNV) infections in people, birds, or mosquitoes to the CDC. Arizona is already reporting 57 human cases and one human death. With record heat and rains impacting many parts of the U.S. this summer, some communities are experiencing mosquito activity higher than in recent years. Many of the floodwater mosquitoes surfacing are aggressive biters, but they don’t present a health risk. However, there are several mosquito species known to vector disease-causing agents that have communities on alert. Areas with historically high trap counts have program managers seeking additional support – from the ground and the air.

Reno County, KS chose to conduct an aerial adulticide application to reduce Culex populations. Moab, UT chose an aerial mission that focused on reducing larval populations. The goal in Moab was to prevent larvae from emerging and becoming yet another generation of biting adults that could attack a community seeking relief from mosquito populations as well as protection from the diseases they may carry. While a few other mosquito-borne diseases have been detected in the U.S. in 2019, such as eastern equine encephalitis, WNV activity is the majority of mosquito-borne disease reporting across the U.S. at the moment.

Public Health and Vector-Borne Diseases in the U.S.

In May 2018, just ahead of summer outdoor activities and vacations, the CDC released new vector-borne disease statistics in its Vital Signs report. The data in the report reflected a staggering increase in the number of reported vector-borne disease cases. From 2004 to 2016, illnesses reported to the CDC from mosquito, tick, and flea bites more than tripled. The report highlighted the increase in mosquito-borne disease outbreaks in the U.S. as well as the uptick in the number of pathogens/diseases transmitted by these vectors.

The emergence of Zika virus and chikungunya virus in the U.S. were provided as examples. As mosquitoes and the disease they carry are more readily transported through global commerce and travel, and changes in climate create ideal habitats for mosquito species to flourish in new areas of the U.S., more people in the states will be living in areas at risk for mosquito-borne disease transmission. This awareness has community leaders, as well as public health and environmental health professionals, taking action to understand threats in their community and prepare, as much as possible, for the unexpected.

Are Mosquito-Borne Diseases Underreported?

On top of the new data highlighting the increase in the number of vector-borne disease cases reported in the U.S., lesser known mosquito-borne diseases also made headlines in 2018. Two diseases you may not be as familiar with are Keystone virus and Jamestown Canyon virus.

In June 2018, University of Florida researchers announced that the journal Clinical Infectious Diseases had confirmed the first human case of the mosquito-borne Keystone virus. The case stemmed back to August 2016, when a teenage boy presented with a fever and severe rash. Initial tests did not confirm Zika virus or other pathogens. While an isolated case, it may indicate that other mosquito-borne viruses are present and not reported in the U.S.

A wife in New Hampshire watched her husband battle unknown health complications, and he ultimately passed away from encephalitis in June of 2018. A month prior to his death, test results showed evidence of Jamestown Canyon virus (JCV) and his family wonders if the virus was the leading contributor. With so many unknowns and the medical community still learning about the virus, additional research and education continue on JCV.

2018 Mosquito-Borne Diseases Reported to the CDC

As in years past, West Nile virus continues to be the most reported and most deadly mosquito-borne disease in the United States. The remainder of this article will focus on WNV, La Crosse encephalitis, eastern equine encephalitis, St. Louis encephalitis, Jamestown Canyon virus, dengue, and one of the most high-profile diseases covered by the media, addressed by public health organizations, and discussed in communities throughout the U.S.in recent years – Zika virus. Data points for this post were obtained from the CDC’s website as of 07/31/19.

wnv-cdc-2018_map

49 out of 50 states and the District of Columbia reported West Nile virus infections in people, birds, or mosquitoes in 2018. Overall, 2,647 cases of WNV were reported in humans, and there were 167 (6.3%) confirmed deaths in 2018. This data shows an increase from the number of human cases reported in 2017 (2,097). It also brings attention to the increase in lives lost, when compared to the 146 (7%) confirmed deaths in 2017 and the 106 (4.9%) confirmed deaths from WNV in 2016.

The states reporting the highest number of human WNV disease cases to the CDC* in 2018:

West Nile Virus

2018 Human U.S. Cases

2018 Cases2018 Deaths
Nebraska25111
California21711
North Dakota2042
Illinois17617
South Dakota1694
Texas14611
Pennsylvania1308
Iowa1049
Michigan1029
New York986

*Statistics include combined count of Neuroinvasive Disease Cases and Non-neuroinvasive Disease Cases

Illinois reported the most human WNV deaths of any state (17). The second highest reports came from Nebraska, California, and Texas – each reporting eleven (11) deaths. Michigan and Iowa each had nine (9) fatalities related to WNV. Virginia also had a notably high number of fatalities (8) compared to its total number of cases (48).

New Hampshire and Hawaii were the only states that did not report human WNV disease cases to the CDC in 2018.

WNV is typically transmitted to humans by mosquitoes that have previously fed upon an infected bird. While over 150 species of mosquitoes have been known to carry WNV, the main vector species in the U.S. are Culex pipiens, Culex tarsalis, and Culex quinquefasciatus. These mosquitoes are all active at night, and most cases of infection occur during the summer months. Approximately 20% of people affected by WNV will experience flu-like symptoms including fever, headache, nausea, muscle pain, and swollen lymph glands. Other symptoms may include a stiff neck, rash, sleepiness or disorientation. Less than 1% of those infected will develop West Nile Encephalitis or Meningitis, which can lead to coma, tremors, convulsions, paralysis, and even death.

To learn more about the symptoms, treatment, and mosquito species that vector this virus, visit our educational page on West Nile virus.


La Crosse Encephalitis Virus (LACV) in 2018

What is mosquito-borne encephalitis?

Mosquito-borne encephalitis can be a severe result of many viruses vectored by mosquitoes. Encephalitis is an inflammation of the brain and central nervous system and is characterized by a high to moderate mortality rate, with some survivors left with permanent physical and mental disabilities. In the U.S., it is geographically wide-spread and is prevalent in several forms: West Nile virus, eastern equine encephalitisJamestown Canyon virus, and several others – including La Crosse. Not all individuals who are infected with one of these viruses will have a severe case that results in encephalitis.

Since La Crosse often presents mild or no symptoms after transmission to humans, it is believed that the virus is underdiagnosed and underreported. Because of this, the CDC only uses LACV neuroinvasive disease cases in their statistics.

The eastern treehole mosquito (Aedes triseriatus) is the primary vector of La Crosse. As the name hints to, this species prefers to utilizes tree holes for their larval habitat. If LACV activity is discovered in a region, individuals living near or frequenting wooded areas where this species lives are more at risk.

In 2018, there were 83 human La Crosse virus neuroinvasive disease cases reported in the U.S. The states reporting the most human cases included: Ohio (39), North Carolina (24), and Tennessee (13). There were no human fatalities reported from LACV in 2018.

la-crosse-cdc-map-2018


To learn more about La Crosse encephalitis virus, visit the CDC’s page on LACV
.


Eastern Equine Encephalitis (EEE) in 2018

Eastern equine encephalitis, also referred to as EEE or Triple E, is a rare but deadly illness for humans. Thankfully, only a few human cases of EEE are reported in the U.S. each year. From 2009 – 2018, between 3 and 15 cases of EEE were reported to the CDC every year in the U.S. During this time period, Florida (13), Massachusetts (10), New York (8), North Carolina (7), and Michigan (7) reported the highest number of cases.

In 2018, there were 6 reported human cases of EEE and 1 of those cases were fatal.

eee_cases_by_year-2018
*Statistics include combined count of Neuroinvasive Disease Cases and Non-neuroinvasive Disease Cases

The reason EEE is less common in humans is that the primary mosquito vector (Culiseta melanura), does not typically feed on humans. It is believed that EEE virus is mainly transmitted to humans and horses by bridge vectors that have contracted the virus by feeding on infected birds. Symptoms typically occur four to ten days after a bite from an infected mosquito and include fever, headache, vomiting, muscle aches, joint pain, and fatigue. In rare cases, infection occurs in the brain and spinal cord leading to sudden high fever, stiff neck, disorientation, seizures, and coma. The mortality rate of those that develop EEE is about 33%, the highest among human arboviruses (a virus transmitted by arthropod vectors) cases reported in the U.S. The disease is also a concern for horses. There is a vaccine available for horses, and horse owners are encouraged to discuss an on-going vaccination schedule with their veterinarians. Currently, there is no human vaccine for EEE.

To learn more about the symptoms, treatment, and mosquito species that vector this virus, visit our educational page on EEE virus.


St. Louis Encephalitis (SLE) in 2018

Prior to the introduction of West Nile virus in 1999, St. Louis Encephalitis virus (SLEV) was the most important epidemic mosquito-borne viral disease in the U.S. Annual reports of SLEV cases fluctuate widely, due to periodic epidemics that occur. Most cases occur in west and central states. From 2009 to 2018, an average of seven cases of SLE disease were reported annually. The last major epidemic occurred in 1975 along the Ohio-Mississippi River Basin when nearly 2,000 cases and 142 deaths were reported.

In 2018, there were 8 reported human cases of SLE and 1 of those cases were fatal.

st-louis-encephalitis-cdc-map-2018


To learn more about the symptoms, treatment, and mosquito species that vector St. Louis encephalitis, visit our educational page on SLE virus
.


Jamestown Canyon Virus in 2018

What is interesting about Jamestown Canyon virus (JCV), is that it behaves a little differently than a few of the viruses the public may be more familiar with. West Nile virus (WNV) and Zika virus rely on a reservoir host to perpetuate the virus, as the mosquito cannot pass it on to their offspring. With JCV, in addition to having reservoir hosts, such as deer, this virus can also have transovarian transmission, which means the parent arthropod (in this case a mosquito) can pass the disease pathogen to their offspring. This is not completely uncommon. Rocky Mountain spotted fever is a vector-borne disease that is transmitted through an infected tick carrying the bacterium Rickettsia rickettsii. The bacterium can be transmitted to offspring in this way as well.

JCV was first discovered in Culiseta mosquitoes in Jamestown, Colorado, in 1961. Since 1961, it has been found in various mosquito species (AedesCulexCoquillettidia), mammals, and humans across North America.

In 2018, there were 32 cases of Jamestown Canyon virus reported in the U.S. The majority of the cases were reported from Wisconsin (23).

To learn more about this virus, read our blog on Jamestown Canyon virus.


Zika Virus (ZIKV) in 2018

Overall in 2018, Zika virus (ZIKV) activity slowed within the United States. There were 0 cases of locally-acquired ZIKV and 0 sexually-acquired cases. However, there was continued activity in travel-associated reports of the disease, with 72 travel-acquired cases documented during the year. Over 50% of the travel-acquired cases were from individuals returning to Florida and California from abroad.

U.S. territories also had a substantial drop in reported cases over 2017. In the territories, there were 147 locally-acquired cases and 1 travel-associated case. There were 0 cases reported through other routes. The CDC notes that sexually-acquired cases are not reported for U.S. territories because with local transmission of Zika virus it is not possible to determine whether infection occurred due to mosquito-borne or sexual transmission.

Despite the decreases, VDCI remains vigilant in monitoring ZIKV activity around the globe so that we are able to provide support should another outbreak occur. VDCI partnered with the CDC in several U.S. territories in 2016 to help combat the spread of Zika virus.

Many individuals learned about Zika during the outbreaks in South and North America; however, the virus was first discovered in 1947 in the Zika Forest of Uganda. In the Americas, it has only been linked to transmission by Aedes aegypti or the Yellow Fever mosquitoAe. aegypti is also responsible for the transmission of dengue virusyellow fever virus, and chikungunya virus. In other parts of the world, the virus has been detected in Aedes albopictus or the Asian tiger mosquito; hence, it is possible that Ae. albopictus could vector the virus in the Americas.

To learn more about the symptoms, treatment, and mosquito species that vector this virus, visit our educational page on Zika virus.


Dengue Virus in 2018

Dengue virus is transmitted by certain Aedes mosquitoes and considered a major global threat as our world’s urban landscape grows. Beyond the increase in desirable habitats for the container-breeding species, the virus has four strains (multiple serotypes) making it complicated for medical professionals to manage. Chikungunya virus shares similar symptoms to dengue and provides those bitten with immunity from future chikungunya infections. Unfortunately, with multiple strains of dengue, an individual is more likely to be hospitalized or die if infected with more than one serotype. Those previously infected or individuals with a weakened immune system should take even greater precautions.

The United States has experienced local outbreaks of dengue in Hawaii (2015), near the Texas-Mexico border (2013), and in Florida. Except for 2017, Florida reported locally-transmitted cases of dengue annually between 2010 – 2018. Larger outbreaks have occurred within U.S. Territories such as Puerto Rico, the U.S. Virgin Islands, and U.S.-affiliated Pacific Islands. A portion of the United States is at a higher risk because of climate and the presence of certain Aedes mosquitoes.

In 2018, there were 2 reported human cases of locally-acquired dengue virus. Texas (1) and Florida (1).

To learn more about the symptoms, treatment, and mosquito species that vector this virus, visit our educational page on dengue
.


 

Monitoring Real-Time U.S. Mosquito-Borne Disease Activity

The CDC has a number of tools in place to help citizens and organizations track vector-borne diseases. The CDC’s ArboNet map provides an illustrated overview of mosquito and other vector-borne activity across the U.S. You can view this live map and archival maps which, including:

  • West Nile Virus (WNV)
  • St. Louis Encephalitis (SLE)
  • Eastern Equine Encephalitis (EEE)
  • La Crosse (LAC)
  • Dengue (DEN) locally-acquired and travel-associated
  • Chikungunya (CHIK) locally-acquired and travel-associated
  • Zika Virus (ZIKA) locally-acquired and travel-associated
  • Powassan Virus (a tick-borne disease)

Utilize the tabs across the top of the ArboNet map to choose the specific vector-borne disease to track and the drop-down menu at the right to select the year. Note: There are times where the CDC’s disease page and the ArboNet map are not in sync. It can be beneficial to reference both resources to ensure you have the most up-to-date disease reporting. Communities may also report disease cases and probably diseases cases on their individual website prior to reporting to the CDC. We encourage all individuals to take personal protection measures and monitor local disease activity via resources available within your community.

west-nile-virus-2018-cdc-arbonet

This 2018 map from CDC’s ArboNet shows West Nile virus activity across the U.S. in 2018.


VDCI is committed to
public education and spreading awareness throughout the U.S. about the dangers of mosquito-borne diseases and their preventability, with the overarching goal of reducing illness and fatality statistics. Our dedicated and experienced team works tirelessly with local governments to prevent the spread of mosquito-borne diseases in all of the contracts we service from coast to coast. We hope everyone has a safe summer.

If you would like more information about any aspect of an Integrated Mosquito Management (IMM) Plan, including mosquito surveillancedisease testingadult control, aerial applications, resistance testing, or creating an emergency response plan (major flood event or disease outbreak) – please contact Vector Disease Control International (VDCI).

In addition, our team has played an integral role in disaster relief and disease outbreak situations for over 20 years. With our fleet of over 200 trucks and 12 aircraft, VDCI is the only company in the country that can internally manage all aspects of an integrated mosquito management program, from surveillance and disease testing to ground and aerial operations for seasonal needs or emergency response situations.

We are determined to protect the public health of the communities in which we operate.

Contact Us to Learn More About Effective Mosquito Management Strategies:

VDCI_Logo_squareSince 1992, Vector Disease Control International (VDCI) has taken pride in providing municipalities, mosquito abatement districts, industrial sites, planned communities, homeowners associations, and golf courses with the tools they need to run effective mosquito control programs. We are determined to protect the public health of the communities in which we operate. Our mosquito control professionals have over 100 years of combined experience in the field of public health, specifically vector disease control. We strive to provide the most effective and scientifically sound mosquito surveillance and control programs possible based on an Integrated Mosquito Management approach recommended by the American Mosquito Control Association (AMCA) and Centers for Disease Control and Prevention (CDC). VDCI is the only company in the country that can manage all aspects of an integrated mosquito management program, from surveillance to disease testing to aerial application in emergency situations.

A New Dawn for Fighting Mosquito-Borne Diseases

Utilizing New Technologies to Protect Public Health

Over recent decades many mosquito-borne diseases have resurfaced or emerged and spread rapidly. From Zika, dengue to West Nile fever and chikungunya. Even malaria, which has had long-term global efforts to eradicate it has recently shown signs of increasing.

Many of these diseases have no specific treatment and the limited medicines available for some are facing resistance. Insecticides used to control mosquitoes are also facing resistance. On many fronts, innovations are urgently needed to control old diseases and prevent new ones from spreading.

Scientists in fields as diverse as biochemistry, genomics, entomology, computing, remote sensing, avionics, artificial intelligence, robotics, and aerospace engineering are combining their resources to develop new ways to fight diseases.

Here are a few examples of some recent scientific developments that are bringing a new dawn in the fight against the global threat of mosquito-borne diseases.

Fighting Insecticide Resistance with Next-Generation Insecticides

In recent decades Anopheles and Aedes mosquito populations in various parts of the world have built up resistance to many of the available insecticides and larvicides used for vector control. Without new products vector control is “doomed to failure”, according to IVCC.

Two new-generation insecticides were approved by WHO in 2017 and are being distributed in malaria areas for use in IRS programs by the NgenIRS project. Since 2016 the project has supported operations in 12 African countries and bought over 4.5 million bottles of the new insecticides.

New Odors to Attract and Repel Mosquitoes

Mosquitoes find human hosts by sensing the carbon dioxide we breathe out. But when they get close they locate sites for feeding by detecting volatile chemicals given off by human skin. Researchers at the University of California Riverside used modern chemical screening techniques to test half a million compounds in a chemical database to find those that could trigger mosquito sensing organs.

They chose two compounds that are already in common use, so don’t need lengthy and costly safety testing, to study further:

  • ethyl pyruvate, which is a food flavoring with a fruity flavor: this was found to reduce Aedes aegypti attraction
  • cyclopentanone, a mint-smelling flavor and fragrance: this was a powerful attractant for Culex quinquefasciatus mosquitoes

Robotics, Gene Sequencing, and Cloud Computing to Detect Diseases Early

Rentokil_728x300_WMD_Blog Imagery_City Scape (1)

Project Premonition is developing a high-tech system to identify potential disease outbreaks before they happen by capturing and analyzing the DNA of mosquitoes that have fed on local animals that could be reservoirs of diseases.

The project is a collaboration between Microsoft Research (MSR) and several U.S. universities. The project is developing:

  • Autonomous drones that can locate mosquito hotspots in complex environments containing trees and buildings
  • Robotic traps to collect and identify mosquito specimens
  • Genomics, cloud computing, and machine learning algorithms to analyze the DNA and RNA in the mosquito samples
    The genomics part of the project can already identify the correct mixture of organisms — animals, mosquitoes, and pathogens — with 99.9% accuracy.

Releasing Mosquitoes Infected with Wolbachia Bacteria

In July this year, the Commonwealth Scientific and Industrial Research Organisation (CSIRO) announced the successful results of a project that released millions of sterile male Aedes aegypti mosquitoes on the Cassowary coast in Queensland, Australia. The project uses new techniques developed by Verily (owned by Alphabet, the parent company of Google) for large-scale rearing, sorting out the males, infecting them with Wolbachia bacteria, and releasing large numbers of the mosquitoes. The Wolbachia prevents the females producing viable eggs.

Verily is also developing software, monitoring tools, sensors, and traps to indicate the mosquito hotspots where the treatment is most effective. The early results show that local Aedes mosquito populations were reduced by 80% – a promising example of the potential of new scientific developments in fighting the global threat of mosquito-borne diseases.

A Gut Feeling to Blocking Diseases

The midgut of mosquitoes is the initial site of infection for a range of diseases, therefore finding a way to block infections there will also block transmission to humans. Many research projects in multiple disciplines are looking at novel ways to do this, including:

Preventing Fungal Infections

Researchers at Johns Hopkins University in the U.S. found that a common fungus, Talaromyces, can infect Aedes aegypti mosquitoes and make them more susceptible to the dengue virus. The researchers also found that a Penicillium fungus made Anopheles mosquitoes more susceptible to infection with the malaria parasite. The research suggests that antifungal solutions are a potential alternative to insecticide spraying to protect mosquitoes from diseases they might spread to humans.

Biochemical Modification of the Mosquito Gut

Another study at Colorado State University has made the first comprehensive analysis of the complex biochemical interactions that occur in a mosquito during a dengue virus infection of the cells lining the gut. Using high-resolution mass spectrometry the researchers identified several biochemical pathways in the mosquito that are required for the virus to replicate. These are now targets for further research to find ways to block them.

Knocking Out Mosquito Genes

Another team of researchers at Johns Hopkins University developed a new gene-editing procedure for Anopheles mosquitoes using a tool called CRISPR/Cas9. Their procedure knocks out the Anopheles mosquito gene FREP1 that enables the Plasmodium parasite to infect the cells lining the midgut. The mutant mosquitoes showed a significant decrease in infection with the parasite. Further work is needed, however, before they can be released into the wild and their prospective impact in reducing the threat of mosquito-borne diseases can be examined.

New Antimalarials

Medicines for Malaria Venture (MMV) has a partnership network of over 400 pharmaceutical, academic, and endemic-country partners in 55 countries developing drugs to protect against malaria.

Since its foundation in 1999 the network has brought seven new medicines to market that are already being used to prevent and treat the disease. As recently as July this year the US FDA endorsed tafenoquine, another medicine produced under the program. This targets the dormant liver stage of Plasmodium vivax and is the first new medicine for 60 years for this type of treatment.

The Future

The future for controlling mosquito-borne diseases is looking more promising as scientific developments across many disciplines are providing new ways of treating diseases and controlling mosquitoes.

VDCI is proud to be a member of the Rentokil Steritech family of companies in North America. Rentokil Steritech is a pest control business with operations all over the world. Working with them, we are confident that our history of service excellence will continue to develop and improve. Our mission is to protect people and enhance lives through our technical experts.

As part of Rentokil’s commitment to fighting mosquito-borne diseases, the company is establishing a new global center of excellence for mosquito control in North America.

Listen to Andy Ransom, CEO of Rentokil Initial, discuss the size of the threat from mosquitoes and what Rentokil is doing to help in commemoration of World Mosquito Day August 20th.

Contact Us to Learn More About Effective Mosquito Prevention Strategies:

VDCI_Logo_square Since 1992, Vector Disease Control International (VDCI) has taken pride in providing municipalities, mosquito abatement districts, industrial sites, planned communities, homeowners associations, and golf courses with the tools they need to run effective mosquito control programs. We are determined to protect the public health of the communities in which we operate. Our mosquito control professionals have over 100 years of combined experience in the field of public health, specifically vector disease control. We strive to provide the most effective and scientifically sound mosquito surveillance and control programs possible based on an Integrated Mosquito Management approach recommended by the American Mosquito Control Association (AMCA) and Centers for Disease Control and Prevention (CDC). VDCI is the only company in the country that can manage all aspects of an integrated mosquito management program, from surveillance to disease testing to aerial application in emergency situations.

Public Health: U.S. Mosquito-Borne Diseases

Mosquito lab image

Deep Dive Into Common Mosquito-Borne Diseases

There are really only two reasons to control mosquitoes; to avoid nuisance biting, and to preclude the spread of mosquito-borne disease. Everyone recognizes that mosquitoes can be a terrible blood feeding nuisance, but many people do not realize the magnitude of the health threat that they represent globally. Some of the world’s most deadly diseases are carried and transmitted by mosquitoes. It is estimated that up to a million people die every year from mosquito-borne illness with many countries around the world ravaged by malariayellow fever, and dengue-hemorrhagic fever. What is the history and what are the current local cases of mosquito-borne disease in the U.S.? 

Malaria: The World's Deadliest Mosquito-Borne Disease has a History in the U.S.

Malaria is a disease caused by a Plasmodium parasite and is the leading cause of mosquito-borne deaths throughout the world. In the past, local malaria cases were reported within the U.S. It wasn’t until after 1950 that malaria was considered eliminated from the country, due to large-scale mosquito control efforts and swamp drainage. While the disease is not currently a threat, one of the primary carriers of the disease parasite in the pre-1950s U.S. – is far from eliminated. Anopheles quadrimaculatus (also known as the Common Malaria Mosquito) is distributed throughout the eastern United States, often occurring in huge numbers in the southeastern states, especially along the Gulf of Mexico. This fact reinforces the importance of robust surveillance and disease testing programs in areas where the species inhabits.

What Mosquito-Borne Diseases are in the U.S.?

In more recent years, West Nile virus, several types of encephalitis, and dog heartworm have been the primary mosquito-borne diseases in the U.S. Additionally, Zika virus, dengue fever, and chikungunya have emerged over the past couple of years as threats to human health in the United States, South America, and the Caribbean.

What is Mosquito-Borne Encephalitis?

Mosquito-borne encephalitis can be a severe result of many viruses vectored by mosquitoes. In the U.S., it is geographically wide-spread and is prevalent in several forms: West Nile virus (WNV), La Crosse encephalitis (LAC), eastern equine encephalitis (EEE), Jamestown Canyon virus (JCV), and several others. Encephalitis is an inflammation of the brain and central nervous system and is characterized by a high to moderate mortality rate, with some survivors left with permanent physical and mental disabilities.

West Nile Virus: #1 Mosquito-Borne Disease Threat in the U.S.

West Nile virus, which in severe cases can cause encephalitis, entered the U.S. along the east coast in 1999 and has had serious ongoing implications for the rest of North America as it has spread across the country. 47 out of 50 states and the District of Columbia reported West Nile virus infections in people, birds, or mosquitoes in 2017.

WNV is typically transmitted to humans by mosquitoes that have previously fed upon an infected bird. While over 150 species of mosquitoes have been known to carry WNV, the primary vector species in the U.S. are Culex pipiensCulex tarsalis, and Culex quinquefasciatus. These mosquitoes are all active at night, and most cases of infection occur during the summer months. Approximately 20% of people affected by WNV will experience flu-like symptoms including fever, headache, nausea, muscle pain, and swollen lymph glands. Other symptoms may include a stiff neck, rash, sleepiness or disorientation. In severe cases, an individual can develop West Nile Encephalitis or Meningitis, which can lead to coma, tremors, convulsions, paralysis, and even death.

2003 was the largest WNV outbreak in the U.S. with 9,862 cases reported and 264 deaths. 2012 was the deadliest year for WNV in the U.S., with 286 deaths reported to the CDC. West Nile virus is a concern in North American bird populations and remains the #1 mosquito-borne disease threat to humans in the U.S., with over 46,000 cases reported between 1999-2016.

Chikungunya: A Human Virus

WNV, EEE, LAC, and a few other mosquito-borne encephalitis viruses have an animal reservoir and cannot be transmitted from human to mosquito. Chikungunya is a human virus. Mosquitoes become infected when they feed on a person already infected with the virus and then spread the virus by feeding on other humans. Because of this ability, the virus has the potential to spread quickly, especially in urban areas with larger populations. The virus first reached the Americas in 2013, with local cases reported in the U.S. in Florida (2014) and Texas (2015).

Dengue Virus: Enjoying Urban Environments

Dengue virus, another human virus, is transmitted by certain Aedes mosquitoes. On a global level, the virus is considered a significant threat as our world’s urban landscapes grow. Beyond the increase in desirable habitats for the container-breeding species, the virus has four strains (multiple serotypes) making it complicated for medical professionals to manage. Chikungunya virus shares similar symptoms to dengue and provides those bitten with immunity from future chikungunya infections. Unfortunately, with multiple strains of dengue, an individual is more likely to be hospitalized or die if infected with more than one serotype. Dengue is considered under reported or misclassified. The World Health Organization posted an update on the virus globally, citing research1 that estimates the real number of dengue infections could be close to 390 million annually.

The United States has experienced local cases of dengue in Florida, Hawaii, and near the Texas-Mexico border. Larger outbreaks have occurred within U.S. Territories, including Puerto Rico, the U.S. Virgin Islands, and U.S.-affiliated Pacific Islands.

Heartworm Disease: Infecting Our Four-Legged Friends

Heartworm Prevention and Dogs

In addition to human cases of mosquito-borne disease, there is a growing concern for pet owners. Dirofilaria immitis, commonly referred to as heartworm, is a parasitic roundworm that infects a variety of mammals. Heartworm is found throughout the world and has been reported in all states in the U.S. The natural host is dogs. Infection in dogs can lead to heartworm disease and, if left untreated, severe physical damage and death may occur. Fortunately, for felines, most worms in cats don’t survive to the adult stage. Prevention is an option, for both dogs and cats, and should be discussed with your veterinarian. Although isolated human infections have been reported, heartworm is not currently recognized as a human health problem.

Mosquitoes Abundant and Problematic

As an individual, if you’ve ever been driven inside by biting mosquitoes or have chased the pesky invaders around the bedroom in the middle of the night, you may consider 1 or 2 mosquitoes – too many. When mosquitoes become abundant and problematic, there becomes an even greater need for control efforts. Hurricanes, such as Harvey and Irma in 2017, have the ability to create vast areas of standing water that produce extreme mosquito populations and make the already difficult disaster relief efforts even harder and more dangerous. With or without a natural disaster, economic losses can be considerable for businesses or travel destinations that are considered uninhabitable or unsuitable due to unmanaged environments creating large populations of one of nature’s deadliest and least popular creatures – the mosquito.

1 Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL et.al. The global distribution and burden of dengue. Nature;496:504-507.

Contact Us to Learn More About Effective Mosquito Prevention Strategies:

VDCI_Logo_square Since 1992, Vector Disease Control International (VDCI) has taken pride in providing municipalities, mosquito abatement districts, industrial sites, planned communities, homeowners associations, and golf courses with the tools they need to run effective mosquito control programs. We are determined to protect the public health of the communities in which we operate. Our mosquito control professionals have over 100 years of combined experience in the field of public health, specifically vector disease control. We strive to provide the most effective and scientifically sound mosquito surveillance and control programs possible based on an Integrated Mosquito Management approach recommended by the American Mosquito Control Association (AMCA) and Centers for Disease Control and Prevention (CDC). VDCI is the only company in the country that can manage all aspects of an integrated mosquito management program, from surveillance to disease testing to aerial application in emergency situations.

Vector-Borne Disease Spotlight: Jamestown Canyon Virus

Aedes_aegypti_Adult_Mosquitoes

Exploring the Impact of Mosquito-Borne Diseases

What? There is another virus that can be transmitted by mosquitoes?! Yes. Mosquitoes are the deadliest animals in the world, and Jamestown Canyon virus is another virus on the long list of diseases vectored by these arthropods.

What is interesting about Jamestown Canyon virus (JCV), is that it behaves a little differently than a few of the viruses the public may be more familiar with. West Nile virus (WNV) and Zika virus rely on a reservoir host to perpetuate the virus, as the mosquito cannot pass it on to their offspring. With JCV, in addition to having reservoir hosts, such as deer, this virus can also have transovarian transmission, which means the parent arthropod (in this case a mosquito) can pass the disease pathogen to their offspring. This is not completely uncommon. Rocky Mountain spotted fever is a vector-borne disease that is transmitted through an infected tick carrying the bacterium Rickettsia rickettsii. The bacterium can be transmitted to offspring in this way as well.

JCV was first discovered in Culiseta mosquitoes in Jamestown, Colorado, in 1961. Since 1961, it has been found in various mosquito species (AedesCulexCoquillettidia), mammals, and humans across North America.

Aedes_aegypti_Adult_Mosquitoes

Is Jamestown Canyon Virus Common?

Jamestown Canyon virus is an orthobunyavirus of the California serogroup. This is the same group that was mentioned in the news last month when it was discovered that a boy in Florida had been infected with the Keystone virus, another mosquito-borne disease, that hadn’t previously been found in humans. JCV was not considered a nationally notifiable disease until a few years back, and states are not mandated to report to the CDC. Depending on local data collection, staff reporting, and even local municipal funding it’s often hard to find a clear picture of disease incidence rates. Only 9 cases of JCV, in the U.S., have been recognized by the CDC, from 2000 to 2012. In 2013, testing for the JCV antibody began at the CDC, and the number of human cases reported increased to 22 in one year! From 2014 to 2016, between 11 to 15 cases were reported each year; however, JVC is likely endemic through most of the United States. It is thought to be under-recognized in the U.S. and Canada because most cases are asymptomatic (showing no symptoms). The lack of awareness can be concerning for individuals who may be more susceptible to the disease, such as the young, elderly, and those with a compromised immune system.

*Data points obtained from www.cdc.gov

How Are Individuals Affected by Jamestown Canyon Virus?

JCV is transmitted during the summer by a few different mosquito species within the United States and Canada. As far as the severity of the disease goes, about 68% of reported cases to the CDC have been considered neuroinvasive (capable of infecting the nervous system). That is a little higher than WNV but lower than La Crosse encephalitis or Eastern equine encephalitis (EEE). The disease onset time and symptoms are similar to that of WNV. A person might develop a sore throat, rash, fever, vomiting, and/or nausea 2 days to 2 weeks after being bitten. Just like many other arboviruses, JCV can cause meningitis or meningoencephalitis. At this time, along with other arboviral diseases, there is no treatment for JCV.

A wife in New Hampshire watched her husband battle unknown health complications, and he ultimately passed from encephalitis in June of 2018. A month prior to his death, test results showed evidence of Jamestown Canyon virus and his family wonders if the virus was the leading contributor. With so many unknowns and the medical community still learning about the virus, additional research and education continue on JCV.

integrated mosquito management 4D's

Can You Avoid Jamestown Canyon Virus Transmission?

It is important to become familiar with symptoms of vector-borne diseases that have been documented in your region, especially for individuals who work or spend a lot of recreational time outdoors when vectors are active. The best way to keep from contracting mosquito-borne disease is local vector management measures and personal protection efforts. So what CAN people do to protect themselves from mosquito bites, and contracting Jamestown Canyon virus? It sounds simple and obvious, but avoid being bitten.

When outside during dusk or dawn, try to wear loose-fitting, long-sleeve, light-colored clothing. Also, use an EPA-approved mosquito repellent on exposed skin. When you are in your yard, take a look around at items that can hold water. Mosquitoes will lay eggs in a receptacle as small as a plastic bottle cap. Inspect tires, gardening items, sporting equipment, bird baths, clogged gutters, and low areas in your yard. An area or object that can hold water for more than 4 days can be a potential breeding site for mosquitoes.

Community leaders and mosquito management professionals continue to research and implement efforts to protect public health – but everyone can play a role. By practicing source reduction on your property to prevent larval habitats and taking personal protection measures to prevent mosquito bites, you are aiding in the reduction of mosquito populations and reducing the risk of mosquito-borne disease.

Contact Us to Learn More About Effective Mosquito Prevention Strategies:

VDCI_Logo_square Since 1992, Vector Disease Control International (VDCI) has taken pride in providing municipalities, mosquito abatement districts, industrial sites, planned communities, homeowners associations, and golf courses with the tools they need to run effective mosquito control programs. We are determined to protect the public health of the communities in which we operate. Our mosquito control professionals have over 100 years of combined experience in the field of public health, specifically vector disease control. We strive to provide the most effective and scientifically sound mosquito surveillance and control programs possible based on an Integrated Mosquito Management approach recommended by the American Mosquito Control Association (AMCA) and Centers for Disease Control and Prevention (CDC). VDCI is the only company in the country that can manage all aspects of an integrated mosquito management program, from surveillance to disease testing to aerial application in emergency situations.

2017 Mosquito-Borne Disease Year in Review

Exploring Mosquito-Borne Diseases In the U.S.

In 2017, the scientific community, the public, and the press maintained their interest in the Zika virus outbreak of 2016. Articles surfaced on the potential long-term health complications attributed to contracting the virus. The public received extra education on personal protective measures to reduce the spread of Zika. And the scientific community reviewed trusted and experimental methods to prevent future outbreaks.
 
In addition to Mother Nature bringing new mosquito-related problems to Texas and Florida last year, in the floodwaters left by Hurricanes Harvey and Irma, both states reported the only locally-acquired U.S. cases of Zika virus for the second year in a row. 
There were several mosquito-borne diseases reported in the United States in 2017. In this blog, we will focus on: West Nile Virus (WNV), Eastern equine encephalitis (EEE), and Zika. WNV remains the most common virus transmitted by mosquitoes to humans in the U.S. as well as responsible for taking the highest number of human lives.

All of the data points in this post were obtained from the Center for Disease Control (CDC)’s website as of 02/13/2018.

West Nile Virus (WNV)

west-nile-virus-wnv-2017-incidence-cdc-map-united-states-01092018-200x127.jpg47 out of 50 states and the District of Columbia have reported West Nile virus infections in people, birds, or mosquitoes in 2017. Overall, 2,002 cases of WNV were reported in humans, and there were 121 (6%) confirmed deaths in 2017. While this data shows a decrease in the number of human cases reported in 2016 (2,149), it also brings attention to the increase in lives lost, when compared to the 106 (5%) confirmed deaths in 2016. The states reporting the highest number of WNV disease cases* in 2017 include:

California: 509 cases, 28 deaths
Texas: 133 cases, 5 deaths
Arizona: 109 cases, 8 deaths
Illinois: 87 cases, 5 deaths
South Dakota: 73 cases, 4 deaths
 

Georgia did not report as many WNV cases (47) as several other areas of the country; however, the state reported one of the highest numbers (7) of confirmed lives lost as a result of the virus.

*Numbers combine Neuroinvasive Disease Cases and Non-neuroinvasive Disease Cases

WNV is typically transmitted to humans by mosquitoes that have previously fed upon an infected bird. While over 150 species of mosquitoes have been known to carry WNV, the main vector species in the U.S. are Culex pipiens, Culex tarsalis, and Culex quinquefasciatus. These mosquitoes are all active at night, and most cases of infection occur during the summer months. Approximately 20% of people affected by WNV will experience flu-like symptoms including fever, headache, nausea, muscle pain, and swollen lymph glands. Other symptoms may include a stiff neck, rash, sleepiness or disorientation. Less than 1% of those infected will develop West Nile Encephalitis or Meningitis, which can lead to coma, tremors, convulsions, paralysis, and even death.

To learn more about the symptoms, treatment, and mosquito species that vector this virus, visit our educational page on West Nile virus.

Eastern Equine Encephalitis (EEE)

eee-eastern-equine-encephalitis-virus-cases-by-state-2007–2016_cdc-arbonet-400x232.jpgEastern equine encephalitis, also referred to as EEE or Triple E, is a rare but deadly illness for humans. Thankfully, only a few human cases of EEE are reported in the U.S. each year. The CDC sites that an average of 7 cases of EEE were reported annually in the U.S. from 2007 – 2016. In 2016, there were 7 reported human cases of EEE and 3 of those cases were fatal. As of January 9, 2018, there were 3 human cases of EEE reported to the CDC in 2017.

The reason EEE is less common in humans is that the primary mosquito vector (Culiseta melanura), does not typically feed on humans. It is believed that EEE virus is mainly transmitted to humans and horses by bridge vectors that have contracted the virus by feeding on infected birds. Symptoms typically occur four to ten days after a bite from an infected mosquito and include fever, headache, vomiting, muscle aches, joint pain, and fatigue. In rare cases, infection occurs in the brain and spinal cord leading to sudden high fever, stiff neck, disorientation, seizures, and coma. The mortality rate of those that develop EEE is about 33%, the highest among human arboviruses (a virus transmitted by arthropod vectors) cases reported in the U.S. The disease is also a concern for horses. There is a vaccine available for horses, and horse owners are encouraged to discuss an on-going vaccination schedule with their veterinarians. Currently, there is no human vaccine for EEE.

To learn more about the symptoms, treatment, and mosquito species that vector this virus, visit our educational page on EEE virus.

Zika Virus (ZIKV)

Zika_PDF_ButtonIn 2017, within the United States, there were 4 ZIKV cases of local mosquito-borne transmission, 5 cases acquired via sexual transmission, and 409 travel-associated cases reported to the CDC. The 4 local cases were from Florida (2) and Texas (2), the same states that reported the only local cases in 2016 (Florida: 218 and Texas: 6).

U.S. Territories reported a total of 636 local cases in 2017, a dramatic decrease from the previous year. In 2016, U.S. Territories reported close to 36,000 cases of Zika virus that were likely acquired through local mosquito-borne transmission. VDCI partnered with the CDC in several U.S. territories in 2016 to help combat the spread of Zika virus.

Many individuals learned about Zika during the outbreaks in South and North America; however, the virus was first discovered in 1947 in the Zika Forest of Uganda. In the Americas, it has only been linked to transmission by Aedes aegypti or the Yellow Fever mosquitoAe. aegypti is also responsible for the transmission of dengue virusyellow fever virus, and chikungunya virus. In Africa, the virus was detected in Aedes albopictus or the Asian tiger mosquito; hence, it is possible that Ae. albopictus could vector the virus in the Americas.

When symptoms occur, they typically begin with a mild headache and fever. Within a day or two, a maculopapular rash may appear and can cover many parts of the body. Following the rash, people generally report continued fever, malaise, and body aches. Other symptoms can include diarrhea, constipation, abdominal pain, and dizziness. Treatment for symptoms includes hydration, rest, and the use of acetaminophen to relieve fever. If a pregnant woman is infected with Zika virus, it may result in microcephaly, a birth defect causing underdevelopment of the head and brain in newborn children. Currently, there is no vaccine or cure for ZIKV.

To learn more about the symptoms, treatment, and mosquito species that vector this virus, visit our educational page on Zika virus.

Contact Us to Learn More About Effective Mosquito Prevention Strategies:

VDCI_Logo_square Since 1992, Vector Disease Control International (VDCI) has taken pride in providing municipalities, mosquito abatement districts, industrial sites, planned communities, homeowners associations, and golf courses with the tools they need to run effective mosquito control programs. We are determined to protect the public health of the communities in which we operate. Our mosquito control professionals have over 100 years of combined experience in the field of public health, specifically vector disease control. We strive to provide the most effective and scientifically sound mosquito surveillance and control programs possible based on an Integrated Mosquito Management approach recommended by the American Mosquito Control Association (AMCA) and Centers for Disease Control and Prevention (CDC). VDCI is the only company in the country that can manage all aspects of an integrated mosquito management program, from surveillance to disease testing to aerial application in emergency situations.

2016 Mosquito-Borne Disease Year in Review

integrated mosquito management

Mosquito-Borne Diseases Reported In the U.S.

2016 was a year of intense scrutiny over vector-borne diseases due to the outbreak of Zika virus. The media coverage of Zika has overshadowed several other mosquito-borne diseases that remain a threat within the U.S. In this blog, we will cover three of the many diseases that were transmitted by mosquitoes in 2016: West Nile Virus (WNV), Eastern equine encephalitis (EEE), and Zika. All of the information in this post was taken from the Center for Disease Control (CDC)’s data points and website as of 01/17/2017.

west-nile-virus-wnv-2016-incidence-cdc-map-united-states-01032017.jpgWest Nile Virus (WNV): WNV is the most common virus transmitted by mosquitoes to humans in the United States. WNV is typically transmitted to humans by mosquitoes that have previously fed upon an infected bird. While over 150 species of mosquitoes have been known to carry WNV, the main vector species in the U.S. are Culex pipiens, Culex tarsalis, and Culex quinquefasciatus. These mosquitoes are all active at night, and most cases of infection occur during the summer months. Approximately 20% of people affected by WNV will experience flu-like symptoms including fever, headache, nausea, muscle pain, and swollen lymph glands. Other symptoms may include a stiff neck, rash, sleepiness or disorientation. Less than 1% of those infected will develop West Nile Encephalitis or Meningitis, which can lead to coma, tremors, convulsions, paralysis, and even death.

As of January 17, 2017, 47 out of 50 states and the District of Columbia have reported West Nile virus infections in people, birds, or mosquitoes in 2016. Overall, 2,038 cases of WNV were reported in humans, and there were 94 confirmed deaths (4.61%) in 2016. The total is a slight improvement from 2015, where there were 2,060 human cases and 119 confirmed deaths (5.8%). To learn more about the symptoms, treatment, and mosquito species that vector this virus, visit our educational page on West Nile virus.



Eastern equine encephalitis (EEE):
 EEE, also referred to as Triple E, is a rare but deadly illness for humans. Thankfully, only a few human cases of EEE are reported in the United States each year. From 2004 to 2013, an average of eight cases of EEE were reported annually in the U.S. The reason EEE is less common in humans is that the primary mosquito vector (Culiseta melanura), does not typically feed on humans. It is believed that EEE virus is mainly transmitted to humans and horses by bridge vectors that have contracted the virus by feeding on infected birds. Symptoms typically occur four to ten days after a bite from an infected mosquito and include fever, headache, vomiting, muscle aches, joint pain, and fatigue. In rare cases, infection occurs in the brain and spinal cord leading to sudden high fever, stiff neck, disorientation, seizures, and coma. The mortality rate of those that develop EEE is about 33%, the highest among human arboviruses (a virus transmitted by arthropod vectors) cases reported in the U.S. Currently, there is no human vaccine for EEE. The disease is also a concern for horses; however, a vaccine is available for horse owners.

Although preliminary, five human cases of EEE were reported nationally in 2016. In 2015, there were six reported human cases of EEE and 50% of those cases were fatal. To learn more about the symptoms, treatment, and mosquito species that vector this virus, visit our educational page on EEE virus.


 

Zika Virus (ZIKV):VDCI_Zika_Fact_Sheet_what_you_should_know_about_zika-1.jpg The Zika virus has been prevalent in the news in 2016, but has actually been around since 1947. In the Americas, it has only been linked to transmission by Aedes aegypti. Ae. aegypti is also responsible for the transmission of dengue virus, yellow fever virus, and chikungunya virus. Recently in Africa, the virus was detected in Aedes albopictus or the Asian tiger mosquito; hence, it is possible that Ae. albopictus could vector the virus in the Americas. If a pregnant woman is infected with Zika virus, it may result in microcephaly, a birth defect causing underdevelopment of the head and brain in newborn children. When symptoms occur, they typically begin with a mild headache and fever. Within a day or two, a maculopapular rash may appear and can cover many parts of the body. Following the rash, people generally report continued fever, malaise, and body aches. Other symptoms can include diarrhea, constipation, abdominal pain, and dizziness. Treatment for symptoms includes hydration, rest, and the use of acetaminophen to relieve fever. Currently, there is no vaccine or cure for ZIKV.

As of January 4, 2017, within the U.S., there were 216 cases of ZIKV locally and 4,619 travel associated cases reported to the CDC in 2016. The 216 local cases, from the states of Florida and Texas, have received the most attention from the U.S. media. The U.S. territories (Puerto Rico, U.S. Virgin Islands, and several other U.S. territories) experienced a total of 35,021 locally-acquired cases were reported in 2016. VDCI partnered with the CDC in several U.S. territories in 2016 to help combat the spread of Zika virus and will continue to work with the CDC in 2017 to protect public health. To learn more about the symptoms, treatment, and mosquito species that vector this virus, visit our educational page on Zika virus.

Contact Us to Learn More About Effective Mosquito Management Strategies:

VDCI_Logo_squareSince 1992, Vector Disease Control International (VDCI) has taken pride in providing municipalities, mosquito abatement districts, industrial sites, planned communities, homeowners associations, and golf courses with the tools they need to run effective mosquito control programs. We are determined to protect the public health of the communities in which we operate. Our mosquito control professionals have over 100 years of combined experience in the field of public health, specifically vector disease control. We strive to provide the most effective and scientifically sound mosquito surveillance and control programs possible based on an Integrated Mosquito Management approach recommended by the American Mosquito Control Association (AMCA) and Centers for Disease Control and Prevention (CDC). VDCI is the only company in the country that can manage all aspects of an integrated mosquito management program, from surveillance to disease testing to aerial application in emergency situations.

Zika-Carrying Aedes Aegypti: Municipal Mosquito Control Solutions

city and municipality mosquito services - vdci - markets served - vector management 2 - resized thin

Your Partner In Government Mosquito Management

Based on the spread of Zika virus in 2016, many municipalities are revisiting how they prepare for the 2017 mosquito season.

We previously provided an overview on why Aedes aegypti is a species that is challenging the mosquito control industry. Because of these challenges, mosquito management experts continue to explore new methodologies to manage Aedes aegypti populations, with the goal always being to protect public health by providing the best solutions to the unique needs of communities.

Understanding If A Threat Exists: Surveillance, Monitoring, and Disease Testing

As discussed in our recent blogsurveillance and monitoring of Aedes aegypti require specialized trapping methods, and there are some proven models as well as novel trap designs that provide great insight into the presence and population density of a species within a given area. The discovery of Aedes aegypti in a community does not mean Zika is soon to follow. After identifying captured mosquitoes, the next step should be to conduct disease testing to determine if a threat exists within the community.

A Potential Threat Is Discovered – What Happens Now?

If it is determined that a threat of Zika virus transmission exists, either due to a locally transmitted human case or a trap producing a positive test for Zika virus, mosquito management experts will take appropriate steps to aid in the management of the target species in order to protect public health. The best course of action is to evaluate the threat based upon mosquito density, larval habitat availability, and even local human customs and behaviors.

The levels of complexity involved in controlling this unique species reinforces the need for experienced professionals. Not all mosquitoes or the vector-borne diseases they carry are the same, and we must consider many factors before providing an action plan.

Aedes_aegypti_Adult_Mosquitoes

As mentioned in previous blogs, the Aedes aegypti species is particularly difficult to control due to its breeding preferences and day-time activity. For decades, the specific behavior of this species has impacted how mosquito management professionals have approached controlling this threat to public health. In the past, labor intensive strategies such as door-to-door inspections and education have been the primary method used to combat Aedes aegypti. While these methods certainly still have a place in today’s efforts to control Aedes aegypti, mosquito management experts are especially focused on the novel approaches to control this species. Specifically, newly developed delivery methods of biorational larvicides, such as the naturally occurring soil bacteria Bacillus thuringiensis isrealensis (Bti), a proven larvicide, is a great example of such a novel approach.

Biorational larvicides are utilized to kill the mosquito larvae before they can become adults and spread human pathogens. Historically, the application of Bti was generally site specific, making it labor intensive to control Aedes aegypti breeding in small, artificial containers. However, new product formulations and application technology have made the wide area application of the bacteria possible. In these new formulations, the bacteria is dissolved in water and can reach small containers in backyards or behind commercial buildings to kill mosquito larvae, without an effect on other aquatic organisms. VDCI’s ground-based equipment has the ability to provide this innovative application that allows us to cover more area and do it in less time. Of course, this new application method is just one weapon in our mosquito management arsenal to prevent or manage Zika virus outbreaks, but represents a significant advancement in the ability to control the population of Aedes aegypti in a given community.

Contact Us to Learn More About Effective Mosquito Management Strategies:

VDCI_Logo_squareSince 1992, Vector Disease Control International (VDCI) has taken pride in providing municipalities, mosquito abatement districts, industrial sites, planned communities, homeowners associations, and golf courses with the tools they need to run effective mosquito control programs. We are determined to protect the public health of the communities in which we operate. Our mosquito control professionals have over 100 years of combined experience in the field of public health, specifically vector disease control. We strive to provide the most effective and scientifically sound mosquito surveillance and control programs possible based on an Integrated Mosquito Management approach recommended by the American Mosquito Control Association (AMCA) and Centers for Disease Control and Prevention (CDC). VDCI is the only company in the country that can manage all aspects of an integrated mosquito management program, from surveillance to disease testing to aerial application in emergency situations.

Zika-Carrying Aedes Aegypti: Challenging Mosquito Management

Aedes_aegypti_Adult_Mosquitoes

We recently featured Aedes aegypti, the Yellow Fever Mosquito, in our Mosquito of the Month blog series. In the world of mosquito management, the species is challenging to beat – both as a topic of interest as well as a target with unique behaviors and habitats.

The species has been the focus of much industry news this year because of its ability to transmit Zika virus, a new virus to the Western Hemisphere, that can have effects ranging from mild illness to severe birth defects. This mosquito, as well as many other mosquito species that can transmit human pathogens, has already had an enormous impact on human history. In addition to Zika virus, the Aedes aegypti is also known to carry several other mosquito-borne diseases that have potentially severe medical implications including, yellow fever, dengue, and chikungunya. The increased awareness of the species, combined with 2016 Zika outbreaks and fears of an outbreak in areas where the species resides, have helped influence social behavior and have had an enormous impact on our global economy. The recent effects are most evident as communities try to determine how to properly fund Zika control efforts to protect their residents and individuals evaluate their family planning timeline and reconsider where and when they travel. With all that fear riding on those tiny wings, proper management of this challenging species and the pathogens it carries is obviously prudent.

What’s the challenge? Why can’t we use the same methodologies implemented with the management of other mosquitoes? The answer: Aedes aegypti, like all species, is unique and it has some behaviors that are different from many of the mosquitoes that we target in our efforts to control nuisance populations and protect public health. A separate approach must be considered for this species in both the adult and larval stages of its life-cycle.When considering best practices for the control of adult mosquitoes, many of the species we target, including those able to carry West Nile virus, actively host-seek at night. Meaning, once the sun sets, these mosquitoes are on the wing, actively searching for a blood meal. Aedes aegypti not only doesn’t actively host-seek, it bites primarily during the day. Aedes aegypti is a weak flyer that remains close to its larval home and uses an ambush style method of acquiring its preferred human blood meal: It waits for a person to enter its area where it can see and sense them. It will then cautiously approach its intended victim and extract its dinner, usually from a lower extremity. At night, we typically target the exposed, adult flying mosquitoes with aerial applications and ground applications using Ultra-Low Volume (ULV) mosquito adulticide. Unfortunately, during these applications, Aedes aegypti mosquitoes are resting under leaves and other areas where the pesticide is much less likely to contact them and do its job.

Truck-spraying-treatment

An additional complexity of Aedes aegypti is their preferred environment for laying eggs. The majority of mosquito species seek larger bodies of standing water to lay large numbers of eggs all at once. Aedes aegypti are “container breeders” and lay a few eggs at a time in just about anything that can hold water. The species has evolved to utilize natural containers, like bamboo and tree holes, to manmade containers ranging from discarded tires to backyard flower pots. The high quantity of small containers that the species can turn into a larval habitat requires an experienced team that understands the complexity of larvicide application as well as overall mosquito management for Aedes aegypti.

To control this species, you have to locate many small larval habitats and find the resting locations of the adults. Instead of wide-area applications of larvicides and adulticides that can cover a large area in a short time, it has typically been a much more intimate, labor intensive, and time consuming approach to managing their populations and mitigate disease.

Contact Us to Learn More About Effective Mosquito Management Strategies:

VDCI_Logo_squareSince 1992, Vector Disease Control International (VDCI) has taken pride in providing municipalities, mosquito abatement districts, industrial sites, planned communities, homeowners associations, and golf courses with the tools they need to run effective mosquito control programs. We are determined to protect the public health of the communities in which we operate. Our mosquito control professionals have over 100 years of combined experience in the field of public health, specifically vector disease control. We strive to provide the most effective and scientifically sound mosquito surveillance and control programs possible based on an Integrated Mosquito Management approach recommended by the American Mosquito Control Association (AMCA) and Centers for Disease Control and Prevention (CDC). VDCI is the only company in the country that can manage all aspects of an integrated mosquito management program, from surveillance to disease testing to aerial application in emergency situations.